Notably, SIRT7 expression is upregulated in pancreatic cancer cells, correlating with adverse prognostic outcomes and a heightened resistance to gemcitabine, a cornerstone of pancreatic cancer treatment. The gene discussed is SIRT7; the disease is pancreatic neoplasm.